Asymptomatic SARS-CoV-2 Infection or COVID-19 Vaccination Effect for Severe Multisystem Inflammatory Syndrome in a 6-Year-Old Girl: Case Report and Review of the Literature

    September 2024 in “ ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics ”
    Enrica Manca, Michele di Toma, Marianna Esotico … Angelo Campanozzi
    🚨 The text mentions transient hair loss (telogen effluvium) as a symptom, which is relevant to hair loss and human biology related to hair, but the primary focus is on MIS-C and COVID-19 vaccination effects.
    Studysummary This case report describes a 6-year-old girl who developed MIS-C following COVID-19 vaccination, raising questions about the vaccine's potential role in its pathogenesis for children aged 5 to 11.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Characteristics of Hair Loss After COVID-19: A Systematic Scoping Review Journal of Cosmetic Dermatology · 2022
    2. Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management The Journal of Dermatology · 2022
    3. Hair Loss as a Late Complication of Multisystem Inflammatory Syndrome in Children The Pediatric Infectious Disease Journal · 2021
    4. Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms Skin appendage disorders · 2021
    5. Telogen Effluvium: A Sequela of COVID-19 International Journal of Dermatology · 2020
    6. Hair Loss in Children: Diagnosis and Treatment Current problems in dermatology · 2015